Adaptive Biotechnologies(us:ADPT)

7.41

-6.68%

Updated on 2025-04-03

Open:7.36
Close:7.41
High:8.07
Low:7.36
Prev Close:7.94
Volume:2.83M
Turnover:21.33M
Turnover Ratio:1.90%
Shares:148.58M
MarketCap:1.10B
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-30209148501556100.70%236881
2024-03-3121914236235396.60%2756102
2023-12-3122214358720698.97%365999
2023-09-3021714040934496.99%1659105
2023-06-3022913627232494.21%1368104
2023-03-3123613270022491.97%218682
2022-12-3124613282464992.82%258698
2022-09-3024712978305090.77%458183
dateorgNametotalratiochangeShareschangeRatio
2024-06-30Viking Global Investors Lp2999370820.34%0
2024-06-30Rubric Capital Management Lp140000009.49%350000033.33%
2024-06-30Blackrock Inc.116640027.91%4738834.24%
2024-06-30Matrix Capital Management Company, Lp115725907.85%0
2024-06-30Ark Investment Management Llc114120007.74%8507048.05%
2024-06-30Vanguard Group Inc102269116.94%-2642907-20.54%
2024-06-30Millennium Management Llc92623416.28%84265801008.25%
2024-06-30Nikko Asset Management Americas, Inc.69197784.69%74307112.03%
2024-06-30Sumitomo Mitsui Trust Holdings, Inc.68996314.68%72292411.70%
2024-06-30Massachusetts Financial Services Co /Ma/39120272.65%131970950.91%

About

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Address:1165 Eastlake Avenue East

Market Movers